Literature DB >> 1902432

Isolation and characterization of human pro-urokinase and its mutants accumulated within the yeast secretory pathway.

R Hiramatsu1, S Horinouchi, T Beppu.   

Abstract

Human pro-urokinase (pro-UK) and two pro-UK deletion mutants, one lacking the epidermal growth factor(EGF)-like domain, and the other lacking both the EGF-like domain and the kringle domain, were produced in Saccharomyces cerevisiae. This was done using the yeast GAL7 promoter and the prepeptide sequence of a fungal aspartic proteinase, Mucor pusillus rennin (MPR). Although biologically active and heavily glycosylated pro-UKs were secreted into the culture medium, the amounts were extremely small. On the other hand, large amounts of pro-UKs of a single-chain form were accumulated inside the cells, exceeding 3-4% of total cellular proteins. The intracellular pro-UKs were N-glycosylated, probably with a single core carbohydrate unit, and amino acid sequencing of their N termini revealed that the secretion signal of MPR was correctly processed. Biologically active pro-UKs were recovered in high yields by means of solubilization with 4.5 M guanidine.HCl and subsequent dialysis for refolding. The refolded yeast pro-UK was indistinguishable from human kidney-derived pro-UK in terms of specific enzymatic activity and its secondary structure, as determined by circular dichroism spectroscopy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1902432     DOI: 10.1016/0378-1119(91)90132-u

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  2 in total

1.  The evolution of recombinant thrombolytics: Current status and future directions.

Authors:  Yogender Pal Khasa
Journal:  Bioengineered       Date:  2016-10-03       Impact factor: 3.269

2.  Secretion by Saccharomyces cerevisiae of rat apolipoprotein E as a fusion to Mucor rennin.

Authors:  N Nomura; H Yamada; N Matsubara; S Horinouchi; T Beppu
Journal:  Appl Microbiol Biotechnol       Date:  1995-03       Impact factor: 4.813

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.